Vividion is a biotechnology company focused on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome-wide drug and target discovery. Making accessible the broad set of proteins expressed in human cells, the company’s platform was spun out of the labs of Vividion’s scientific founders, a team of experts in chemical biology and synthetic chemistry from The Scripps Research Institute in La Jolla, CA. Vividion is committed to advancing and applying its pioneering synthetic and proteomic chemistry platforms to create therapeutics that will make a transformative difference in patients.
Cureatr develops a cloud-based medication management software to optimize patient care. It offers healthcare management services that focus on post-discharge medication reconciliation and other medical services triggered by real-time events.
Prealize Health uses machine learning to transform healthcare from reactive to proactive so that more people can live healthier lives. The company identifies next year’s new high-cost members before a high-cost event occurs. And work with clinician teams to precisely target interventions that improve the quality of care and contain costs. Prealize empowers Health Plans, Employers, and Providers to see around the corner by predicting the what, why, and when of future risk. The company was founded in 2015 and based in Palo Alto, California.
Vividion is a biotechnology company focused on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome-wide drug and target discovery. Making accessible the broad set of proteins expressed in human cells, the company’s platform was spun out of the labs of Vividion’s scientific founders, a team of experts in chemical biology and synthetic chemistry from The Scripps Research Institute in La Jolla, CA. Vividion is committed to advancing and applying its pioneering synthetic and proteomic chemistry platforms to create therapeutics that will make a transformative difference in patients.
Vividion is a biotechnology company focused on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome-wide drug and target discovery. Making accessible the broad set of proteins expressed in human cells, the company’s platform was spun out of the labs of Vividion’s scientific founders, a team of experts in chemical biology and synthetic chemistry from The Scripps Research Institute in La Jolla, CA. Vividion is committed to advancing and applying its pioneering synthetic and proteomic chemistry platforms to create therapeutics that will make a transformative difference in patients.
LifeIMAGE is an online network that enables individuals to exchange medical images. LifeIMAGE is interoperable with the hospital EMR to provide integrated access to medical images, from anywhere. Clinicians can exchange medical images with patients and providers, anywhere. It was founded in 2008 and headquartered in Newton, Massachusetts.
Ivenix is a medical technology company that develops a next-generation infusion management system. It is a venture-backed medical device company with a vision to transform infusion delivery in every care setting, globally. The company is focused on bringing its first product to market, a new and innovative infusion management system for hospitals. The system combines integrated state-of-the-art information technology and simplicity with an adaptive fluid delivery platform that continuously measures flow. The company was founded in 2007 and is headquartered in Amesbury, Massachusetts.
Cureatr develops a cloud-based medication management software to optimize patient care. It offers healthcare management services that focus on post-discharge medication reconciliation and other medical services triggered by real-time events.
LifeIMAGE is an online network that enables individuals to exchange medical images. LifeIMAGE is interoperable with the hospital EMR to provide integrated access to medical images, from anywhere. Clinicians can exchange medical images with patients and providers, anywhere. It was founded in 2008 and headquartered in Newton, Massachusetts.
aTyr Pharma is a biotherapeutics company that discovers and develops protein biologics for human therapeutics. The company has established a dominant intellectual property estate surrounding Physiocrine-based compositions and potential therapeutic applications. aTyr’s key programs are focused on immunomodulation disorders in the areas of inflammation and immunity and are in preclinical development. The company's primary focus is ATYR1923, a clinical-stage product candidate which binds to the neuropilin-2 receptor and is designed to down-regulate immune engagement in interstitial lung diseases. The privately held biotech was founded by The Scripps Research Institute Professor Paul Schimmel, a leading aminoacyl tRNA synthetase scientist, and is backed by top life sciences investors Alta Partners, Cardinal Partners, Domain Associates and Polaris Ventures.
Teladoc is a healthcare organization dedicated to improving access to medical services and enhancing patient experiences globally. It offers a range of integrated clinical solutions, including telehealth, expert medical consultations, artificial intelligence, and analytics, aimed at providing high-quality care at lower costs. With a workforce of over 2,000 employees, Teladoc operates in 125 countries and supports communication in more than 20 languages. The company collaborates with employers, hospitals, health systems, and insurers to revolutionize care delivery, ensuring that patients can access medical professionals anytime, day or night. Through its innovative approach, Teladoc seeks to improve health outcomes for individuals worldwide.
Private Equity Round in 2014
Privia Health™ is a technology-driven, national physician enablement company that collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual settings. Its platform is led by industry talent and exceptional physician leadership, and consists of scalable operations and end-to-end, cloud-based technology that reduces unnecessary healthcare costs, achieve better outcomes, and improves the health of patients and the well-being of providers. Through its high-performance physician group (Privia Medical Group), accountable care organization (Privia Quality Network), and population health management programs, Privia works in close partnership with forward-thinking health plans and national payers to better align reimbursements to quality and outcomes. Privia’s proprietary cloud-based technology platform, combined with an innovative approach to patient engagement and physician-driven wellness, focuses on building a better healthcare delivery system and creating a healthier patient population. The company was founded in 2007 and is headquartered in Arlington, Virginia.
Cureatr develops a cloud-based medication management software to optimize patient care. It offers healthcare management services that focus on post-discharge medication reconciliation and other medical services triggered by real-time events.
aTyr Pharma is a biotherapeutics company that discovers and develops protein biologics for human therapeutics. The company has established a dominant intellectual property estate surrounding Physiocrine-based compositions and potential therapeutic applications. aTyr’s key programs are focused on immunomodulation disorders in the areas of inflammation and immunity and are in preclinical development. The company's primary focus is ATYR1923, a clinical-stage product candidate which binds to the neuropilin-2 receptor and is designed to down-regulate immune engagement in interstitial lung diseases. The privately held biotech was founded by The Scripps Research Institute Professor Paul Schimmel, a leading aminoacyl tRNA synthetase scientist, and is backed by top life sciences investors Alta Partners, Cardinal Partners, Domain Associates and Polaris Ventures.
Vitals Consumer Services, LLC specializes in healthcare transparency and engagement solutions for consumers, employers, and health plans. Established in 2006 and headquartered in Lyndhurst, New Jersey, the company offers various tools to assist individuals in navigating their healthcare options. Among its key offerings are an online search tool for finding doctors, a healthcare transparency platform that clarifies health benefits and care choices, and an incentive program that rewards patients for selecting cost-effective care. Vitals serves over 280 million people annually, helping them make informed decisions about their healthcare. As of August 2018, Vitals operates as a subsidiary of WebMD Health Corp, with additional locations in New York, Tulsa, Westborough, and Bedford.
LifeIMAGE is an online network that enables individuals to exchange medical images. LifeIMAGE is interoperable with the hospital EMR to provide integrated access to medical images, from anywhere. Clinicians can exchange medical images with patients and providers, anywhere. It was founded in 2008 and headquartered in Newton, Massachusetts.
QPID Health 's clinical insights software solution is built on the QPID platform, originally developed at the Massachusetts General Hospital to make it easier for clinicians to get value from the patient information stored in electronic health records. The company addresses the urgent need to generate value from the huge investment made in EHRs and the growing mass of electronic clinical data. QPID is EHR agnostic, and automatically delivers context-sensitive information from patient records into point of care and care planning workflows. QPID drives higher clinician productivity and more informed care decisions, for improved patient outcomes and lower costs. The QPID platform uses natural language processing (NLP), machine learning, and a library of thousands of clinical concept searches designed to retrieve digests of clinical information that match how a clinician thinks. Founded in 2013 by Dr. Michael Zalis and Dr. Mitch Harris, QPID is based in Boston and backed by Matrix Partners, Partners Innovation Fund, Massachusetts General Physicians Organization and Cardinal Partners.
Vascular Pharmaceuticals is a drug discovery company developing monoclonal antibody treatments for diabetic nephropathy. The company specializes in the fields of biotechnology, medicine, and healthcare. It was founded in 2005 and headquartered in Tarboro, North Carolina.
Awarepoint is the leader in providing workflow automation and tracking solutions to the acute care hospital marketplace. Real-time Location System (RTLS) solutions have quickly become must-have tools for hospitals tackling asset management, compliance, and efficient patient throughput challenges. Ever increasing numbers of advanced healthcare provider organizations are turning to Awarepoint and our software and technology platform solution as their RTLS-enabled workflow automation provider of choice. Awarepoint's industry leading RTLS solutions portfolio addresses needs throughout the hospital enterprise versus a best-of-breed island approach that forces hospitals to manage a multitude of vendor solutions for asset tracking and patient flow. The company was founded in 2002 and is based in San Diego, California.
LifeIMAGE is an online network that enables individuals to exchange medical images. LifeIMAGE is interoperable with the hospital EMR to provide integrated access to medical images, from anywhere. Clinicians can exchange medical images with patients and providers, anywhere. It was founded in 2008 and headquartered in Newton, Massachusetts.
Medley Health is an innovative, entrepreneurial, technology-driven company. It's backed by top-tier investors and a management team with deep business expertise in healthcare, Internet and web services, as well as next-generation communications technologies.
Verastem Oncology is a late-stage development biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with RAS/MAPK pathway-driven cancers. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition, FAK inhibition, and KRAS G12D inhibition.
Teladoc is a healthcare organization dedicated to improving access to medical services and enhancing patient experiences globally. It offers a range of integrated clinical solutions, including telehealth, expert medical consultations, artificial intelligence, and analytics, aimed at providing high-quality care at lower costs. With a workforce of over 2,000 employees, Teladoc operates in 125 countries and supports communication in more than 20 languages. The company collaborates with employers, hospitals, health systems, and insurers to revolutionize care delivery, ensuring that patients can access medical professionals anytime, day or night. Through its innovative approach, Teladoc seeks to improve health outcomes for individuals worldwide.
Awarepoint is the leader in providing workflow automation and tracking solutions to the acute care hospital marketplace. Real-time Location System (RTLS) solutions have quickly become must-have tools for hospitals tackling asset management, compliance, and efficient patient throughput challenges. Ever increasing numbers of advanced healthcare provider organizations are turning to Awarepoint and our software and technology platform solution as their RTLS-enabled workflow automation provider of choice. Awarepoint's industry leading RTLS solutions portfolio addresses needs throughout the hospital enterprise versus a best-of-breed island approach that forces hospitals to manage a multitude of vendor solutions for asset tracking and patient flow. The company was founded in 2002 and is based in San Diego, California.
Fluidnet was founded in 2002 by a group of medical device professionals who collectively have over 100+ years of industry experience and product innovations. Based on the seacoast of scenic New Hampshire, Fluidnet is just north of Boston, providing access to a rich medical device community and first-rate research and development skills and facilities.
Verastem Oncology is a late-stage development biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with RAS/MAPK pathway-driven cancers. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition, FAK inhibition, and KRAS G12D inhibition.
LifeIMAGE is an online network that enables individuals to exchange medical images. LifeIMAGE is interoperable with the hospital EMR to provide integrated access to medical images, from anywhere. Clinicians can exchange medical images with patients and providers, anywhere. It was founded in 2008 and headquartered in Newton, Massachusetts.
Awarepoint is the leader in providing workflow automation and tracking solutions to the acute care hospital marketplace. Real-time Location System (RTLS) solutions have quickly become must-have tools for hospitals tackling asset management, compliance, and efficient patient throughput challenges. Ever increasing numbers of advanced healthcare provider organizations are turning to Awarepoint and our software and technology platform solution as their RTLS-enabled workflow automation provider of choice. Awarepoint's industry leading RTLS solutions portfolio addresses needs throughout the hospital enterprise versus a best-of-breed island approach that forces hospitals to manage a multitude of vendor solutions for asset tracking and patient flow. The company was founded in 2002 and is based in San Diego, California.
Verastem Oncology is a late-stage development biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with RAS/MAPK pathway-driven cancers. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition, FAK inhibition, and KRAS G12D inhibition.
aTyr Pharma is a biotherapeutics company that discovers and develops protein biologics for human therapeutics. The company has established a dominant intellectual property estate surrounding Physiocrine-based compositions and potential therapeutic applications. aTyr’s key programs are focused on immunomodulation disorders in the areas of inflammation and immunity and are in preclinical development. The company's primary focus is ATYR1923, a clinical-stage product candidate which binds to the neuropilin-2 receptor and is designed to down-regulate immune engagement in interstitial lung diseases. The privately held biotech was founded by The Scripps Research Institute Professor Paul Schimmel, a leading aminoacyl tRNA synthetase scientist, and is backed by top life sciences investors Alta Partners, Cardinal Partners, Domain Associates and Polaris Ventures.
Fluidnet was founded in 2002 by a group of medical device professionals who collectively have over 100+ years of industry experience and product innovations. Based on the seacoast of scenic New Hampshire, Fluidnet is just north of Boston, providing access to a rich medical device community and first-rate research and development skills and facilities.
Awarepoint is the leader in providing workflow automation and tracking solutions to the acute care hospital marketplace. Real-time Location System (RTLS) solutions have quickly become must-have tools for hospitals tackling asset management, compliance, and efficient patient throughput challenges. Ever increasing numbers of advanced healthcare provider organizations are turning to Awarepoint and our software and technology platform solution as their RTLS-enabled workflow automation provider of choice. Awarepoint's industry leading RTLS solutions portfolio addresses needs throughout the hospital enterprise versus a best-of-breed island approach that forces hospitals to manage a multitude of vendor solutions for asset tracking and patient flow. The company was founded in 2002 and is based in San Diego, California.
Teladoc is a healthcare organization dedicated to improving access to medical services and enhancing patient experiences globally. It offers a range of integrated clinical solutions, including telehealth, expert medical consultations, artificial intelligence, and analytics, aimed at providing high-quality care at lower costs. With a workforce of over 2,000 employees, Teladoc operates in 125 countries and supports communication in more than 20 languages. The company collaborates with employers, hospitals, health systems, and insurers to revolutionize care delivery, ensuring that patients can access medical professionals anytime, day or night. Through its innovative approach, Teladoc seeks to improve health outcomes for individuals worldwide.
Inspired Technologies (North Huntingdon, PA) a commercial-stage medical device company focused on auto-titration of oxygen delivery for COPD patients.
aTyr Pharma is a biotherapeutics company that discovers and develops protein biologics for human therapeutics. The company has established a dominant intellectual property estate surrounding Physiocrine-based compositions and potential therapeutic applications. aTyr’s key programs are focused on immunomodulation disorders in the areas of inflammation and immunity and are in preclinical development. The company's primary focus is ATYR1923, a clinical-stage product candidate which binds to the neuropilin-2 receptor and is designed to down-regulate immune engagement in interstitial lung diseases. The privately held biotech was founded by The Scripps Research Institute Professor Paul Schimmel, a leading aminoacyl tRNA synthetase scientist, and is backed by top life sciences investors Alta Partners, Cardinal Partners, Domain Associates and Polaris Ventures.
Awarepoint is the leader in providing workflow automation and tracking solutions to the acute care hospital marketplace. Real-time Location System (RTLS) solutions have quickly become must-have tools for hospitals tackling asset management, compliance, and efficient patient throughput challenges. Ever increasing numbers of advanced healthcare provider organizations are turning to Awarepoint and our software and technology platform solution as their RTLS-enabled workflow automation provider of choice. Awarepoint's industry leading RTLS solutions portfolio addresses needs throughout the hospital enterprise versus a best-of-breed island approach that forces hospitals to manage a multitude of vendor solutions for asset tracking and patient flow. The company was founded in 2002 and is based in San Diego, California.
CodeRyte is the premier provider of computer-assisted coding and clinical data extraction solutions for the healthcare industry. Their sophisticated technology streamlines the coding process and identifies clinically relevant information from medical records. Their clients secure their rightful reimbursement, enhance compliance and efficiency through computer-assisted coding. CodeRyte's data extraction solutions analyze the language of physician narratives and elevate previously undiscovered data for critical treatment and business decisions. Many of the nation's top physician practices, billing companies and academic medical centers rely on CodeRyte as the centerpiece of their coding and data mining operations.
AxoGen, Inc. engages in the development of treatment options for the repair of peripheral nerve injuries. It offers AVANCE Nerve Graft, a human allograft nerve that is used for the repair, replacement, and reconstruction of damaged peripheral nerves. The company accepts orders through phone, fax, or email. It serves surgeons. AxoGen has a strategic tissue recovery partnership with American Tissue Services Foundation (ATSF). The company was founded in 2002 and is based in Alachua, Florida.
Inspired Technologies (North Huntingdon, PA) a commercial-stage medical device company focused on auto-titration of oxygen delivery for COPD patients.
aTyr Pharma is a biotherapeutics company that discovers and develops protein biologics for human therapeutics. The company has established a dominant intellectual property estate surrounding Physiocrine-based compositions and potential therapeutic applications. aTyr’s key programs are focused on immunomodulation disorders in the areas of inflammation and immunity and are in preclinical development. The company's primary focus is ATYR1923, a clinical-stage product candidate which binds to the neuropilin-2 receptor and is designed to down-regulate immune engagement in interstitial lung diseases. The privately held biotech was founded by The Scripps Research Institute Professor Paul Schimmel, a leading aminoacyl tRNA synthetase scientist, and is backed by top life sciences investors Alta Partners, Cardinal Partners, Domain Associates and Polaris Ventures.
Bioconnect Systems offers novel surgical implants and techniques that form precisely controlled vascular connections. The Optiflow family of sutureless anastomotic connectors provides a fast and repeatable method for connecting vessels. Bioconnect Systems was founded in 2006 and headquartered in Fort Washington, Pennsylvania.
Melinta Therapeutics, Inc. is a commercial-stage pharmaceutical company specializing in the discovery, development, and commercialization of anti-infective therapies targeting bacterial infections. The company offers several products, including Baxdela, Vabomere, Orbactiv, and Minocin, which address various acute bacterial skin infections and gram-negative infections. Recognizing the urgent need for new antibiotics to combat drug-resistant infections, Melinta is advancing delafloxacin, currently in Phase 3 development for treating acute bacterial skin and skin structure infections. The company also focuses on developing innovative antibiotics aimed at overcoming resistant pathogens associated with serious hospital infections. Established in 2000, Melinta Therapeutics is headquartered in Morristown, New Jersey, and operates with support from strategic partners in the healthcare sector.
CodeRyte is the premier provider of computer-assisted coding and clinical data extraction solutions for the healthcare industry. Their sophisticated technology streamlines the coding process and identifies clinically relevant information from medical records. Their clients secure their rightful reimbursement, enhance compliance and efficiency through computer-assisted coding. CodeRyte's data extraction solutions analyze the language of physician narratives and elevate previously undiscovered data for critical treatment and business decisions. Many of the nation's top physician practices, billing companies and academic medical centers rely on CodeRyte as the centerpiece of their coding and data mining operations.
CardioOptics is a development-stage medical device company based in Boulder.
[Sirtris Pharmaceuticals](http://www.sirtrispharma.com) (NASDAQ: SIRT) is a biopharmaceutical company focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with aging, including metabolic diseases such as Type 2 Diabetes. via: [Sirtris](http://www.sirtrispharma.com)
Roving Planet
Series C in 2005
Roving Planet, Inc. provides network access control and management solutions for enterprise networks. Its products provide a secure network environment by managing and controlling users, endpoints, connections, and sessions. The company serves enterprise, manufacturing, health, higher education, k-12, and aerospace government industries. Roving Planet, Inc. was founded in 2001 and is headquartered in Westminster, Colorado.
[Sirtris Pharmaceuticals](http://www.sirtrispharma.com) (NASDAQ: SIRT) is a biopharmaceutical company focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with aging, including metabolic diseases such as Type 2 Diabetes. via: [Sirtris](http://www.sirtrispharma.com)
Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the characterization and process engineering of complex molecules. These complex molecules include proteins, polypeptides, and cell surface polysaccharides, such as heparan-sulfate proteoglycans. This results in a diversified product pipeline of complex generic, follow-on biologic and novel drugs. The Company's two most advanced complex generic product candidates target marketed products, which were originally approved by the United States Food and Drug Administration as New Drug Applications. M-Enoxaparin is designed to be a generic version of Lovenox (enoxaparin sodium injection), a low-molecular weight heparin used to prevent and treat deep vein thrombosis. Its second major generic product candidate is M356, a generic version of Copaxone (glatiramer acetate injection), a drug that is indicated for the reduction of the frequency of relapses in patients with relapsing-remitting multiple sclerosis.
Alnylam is the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare genetic, cardio-metabolic, hepatic infectious, and central nervous system (CNS)/ocular diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach for the treatment of a wide range of severe and debilitating diseases.
Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the characterization and process engineering of complex molecules. These complex molecules include proteins, polypeptides, and cell surface polysaccharides, such as heparan-sulfate proteoglycans. This results in a diversified product pipeline of complex generic, follow-on biologic and novel drugs. The Company's two most advanced complex generic product candidates target marketed products, which were originally approved by the United States Food and Drug Administration as New Drug Applications. M-Enoxaparin is designed to be a generic version of Lovenox (enoxaparin sodium injection), a low-molecular weight heparin used to prevent and treat deep vein thrombosis. Its second major generic product candidate is M356, a generic version of Copaxone (glatiramer acetate injection), a drug that is indicated for the reduction of the frequency of relapses in patients with relapsing-remitting multiple sclerosis.
NexCura applications and custom services are made available through an application service provider (ASP) model on Web sites and are used to collect comprehensive clinical data and facilitate communication between patients and their physicians. The aggregate data They collect provides direct value to healthcare organizations, pharmaceutical companies, physicians, and patients.
CardioOptics is a development-stage medical device company based in Boulder.
Providing 24-hour healthcare these days is a tough balancing act. Don't perform without a safety net you can trust. At IntelliCare, they know the ropes. They're a management company for medical call centers, and they work closely with health systems, provider networks and physician groups to make their operations a success. They offer experience, flexibility, commitment -- and a wide range of 24-hour telephonic and Web-based medical call center services that let you focus on what you do best. Making people feel better.
Providing 24-hour healthcare these days is a tough balancing act. Don't perform without a safety net you can trust. At IntelliCare, they know the ropes. They're a management company for medical call centers, and they work closely with health systems, provider networks and physician groups to make their operations a success. They offer experience, flexibility, commitment -- and a wide range of 24-hour telephonic and Web-based medical call center services that let you focus on what you do best. Making people feel better.
IC-USA is a business consulting firm that assists both domestic and foreign nationals in establishing investments. It also offers passive investments for investing, which refers broadly to a buy-and-hold portfolio strategy for long-term investment.
Pointshare is a national leader in connecting local healthcare communities with secure, online business services that enhance communication, create efficiencies, and improve the delivery of care. Pointshare is the only company that has developed the technology, infrastructure, and hands-on service to create a proven, practical solution for automating the day-to-day business transactions of healthcare.
Pointshare is a national leader in connecting local healthcare communities with secure, online business services that enhance communication, create efficiencies, and improve the delivery of care. Pointshare is the only company that has developed the technology, infrastructure, and hands-on service to create a proven, practical solution for automating the day-to-day business transactions of healthcare.